| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 1 | 31 | 2026 | 630 | 4.220 |
Why?
|
| Islets of Langerhans | 14 | 2026 | 284 | 2.790 |
Why?
|
| Insulin-Secreting Cells | 15 | 2026 | 193 | 2.500 |
Why?
|
| CD4-Positive T-Lymphocytes | 18 | 2025 | 636 | 1.590 |
Why?
|
| T-Lymphocytes | 13 | 2026 | 1007 | 1.430 |
Why?
|
| Autoantigens | 8 | 2026 | 138 | 0.990 |
Why?
|
| Insulin | 9 | 2026 | 692 | 0.730 |
Why?
|
| Autoimmunity | 6 | 2021 | 246 | 0.690 |
Why?
|
| T-Lymphocyte Subsets | 7 | 2021 | 241 | 0.680 |
Why?
|
| Pancreas | 5 | 2023 | 154 | 0.660 |
Why?
|
| Antigen Presentation | 8 | 2026 | 240 | 0.630 |
Why?
|
| Epitopes, T-Lymphocyte | 6 | 2026 | 182 | 0.610 |
Why?
|
| Lymph Nodes | 3 | 2017 | 232 | 0.540 |
Why?
|
| T-Cell Antigen Receptor Specificity | 1 | 2017 | 10 | 0.520 |
Why?
|
| HLA-DQ Antigens | 1 | 2016 | 14 | 0.500 |
Why?
|
| HLA-A2 Antigen | 1 | 2016 | 62 | 0.500 |
Why?
|
| Peptides | 10 | 2026 | 588 | 0.380 |
Why?
|
| CD8-Positive T-Lymphocytes | 5 | 2026 | 664 | 0.370 |
Why?
|
| Cytokines | 6 | 2025 | 952 | 0.370 |
Why?
|
| Killer Cells, Natural | 4 | 2006 | 214 | 0.350 |
Why?
|
| Histocompatibility Antigens Class II | 7 | 2019 | 182 | 0.320 |
Why?
|
| Humans | 48 | 2026 | 64796 | 0.320 |
Why?
|
| Lymphocyte Activation | 8 | 2018 | 752 | 0.300 |
Why?
|
| Autoantibodies | 4 | 2025 | 184 | 0.270 |
Why?
|
| Receptors, Antigen, T-Cell | 5 | 2018 | 279 | 0.270 |
Why?
|
| Interleukin-4 | 4 | 2006 | 147 | 0.260 |
Why?
|
| Antigens | 2 | 2018 | 145 | 0.260 |
Why?
|
| B-Lymphocytes | 5 | 2017 | 564 | 0.260 |
Why?
|
| Antigens, CD1 | 7 | 2008 | 41 | 0.250 |
Why?
|
| HLA-C Antigens | 1 | 2026 | 4 | 0.240 |
Why?
|
| Amino Acid Sequence | 7 | 2017 | 1593 | 0.240 |
Why?
|
| Th1 Cells | 4 | 2009 | 171 | 0.240 |
Why?
|
| HLA-B Antigens | 1 | 2025 | 13 | 0.220 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 3 | 2000 | 112 | 0.220 |
Why?
|
| Interferon-alpha | 1 | 2025 | 102 | 0.210 |
Why?
|
| Coxsackievirus Infections | 1 | 2024 | 12 | 0.210 |
Why?
|
| Animals | 17 | 2026 | 21297 | 0.210 |
Why?
|
| Immunotherapy | 2 | 2025 | 267 | 0.200 |
Why?
|
| Epitopes | 3 | 2024 | 292 | 0.200 |
Why?
|
| Neurodegenerative Diseases | 1 | 2025 | 149 | 0.190 |
Why?
|
| Cell Line, Transformed | 3 | 2018 | 97 | 0.180 |
Why?
|
| Mice | 10 | 2026 | 11085 | 0.180 |
Why?
|
| Clone Cells | 7 | 2016 | 112 | 0.180 |
Why?
|
| Antigens, Neoplasm | 1 | 2022 | 129 | 0.170 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 168 | 0.170 |
Why?
|
| Protein Precursors | 1 | 2021 | 85 | 0.170 |
Why?
|
| HLA-DR Antigens | 3 | 2011 | 26 | 0.160 |
Why?
|
| C-Peptide | 3 | 2016 | 23 | 0.160 |
Why?
|
| Adolescent | 7 | 2025 | 6293 | 0.160 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 1999 | 6 | 0.160 |
Why?
|
| Complementarity Determining Regions | 1 | 1999 | 33 | 0.150 |
Why?
|
| Tissue Array Analysis | 2 | 2010 | 39 | 0.150 |
Why?
|
| Adult | 12 | 2025 | 17246 | 0.140 |
Why?
|
| Hybridomas | 1 | 2018 | 63 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2018 | 269 | 0.140 |
Why?
|
| HLA-DRB1 Chains | 3 | 2025 | 16 | 0.140 |
Why?
|
| Antibodies | 3 | 2024 | 187 | 0.140 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2018 | 51 | 0.140 |
Why?
|
| Proinsulin | 1 | 2017 | 3 | 0.130 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2018 | 81 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2025 | 763 | 0.130 |
Why?
|
| Diabetes Complications | 1 | 2018 | 106 | 0.130 |
Why?
|
| Immune Tolerance | 3 | 2016 | 181 | 0.130 |
Why?
|
| Young Adult | 5 | 2025 | 4777 | 0.130 |
Why?
|
| Germinal Center | 1 | 2017 | 39 | 0.130 |
Why?
|
| Cystic Fibrosis | 1 | 2018 | 127 | 0.130 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2016 | 14 | 0.120 |
Why?
|
| Female | 15 | 2026 | 33771 | 0.120 |
Why?
|
| Brain | 1 | 2025 | 1598 | 0.120 |
Why?
|
| Antigens, CD1d | 4 | 2005 | 29 | 0.120 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2016 | 220 | 0.120 |
Why?
|
| Male | 14 | 2025 | 30812 | 0.110 |
Why?
|
| Somatostatin-Secreting Cells | 1 | 2015 | 8 | 0.110 |
Why?
|
| Glucagon-Secreting Cells | 1 | 2015 | 26 | 0.110 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2016 | 206 | 0.110 |
Why?
|
| Molecular Sequence Data | 6 | 2016 | 1985 | 0.110 |
Why?
|
| Fetus | 1 | 2015 | 101 | 0.110 |
Why?
|
| Mice, Inbred NOD | 3 | 2026 | 526 | 0.110 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 2 | 2008 | 25 | 0.110 |
Why?
|
| Cells, Cultured | 7 | 2019 | 2190 | 0.110 |
Why?
|
| Lipids | 2 | 2008 | 326 | 0.110 |
Why?
|
| Dendritic Cells | 4 | 2017 | 533 | 0.100 |
Why?
|
| Immunophenotyping | 3 | 2022 | 195 | 0.100 |
Why?
|
| Child | 4 | 2017 | 4603 | 0.100 |
Why?
|
| Risk Factors | 1 | 2023 | 5396 | 0.100 |
Why?
|
| Alternative Splicing | 2 | 2025 | 138 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 553 | 0.100 |
Why?
|
| Interleukin-17 | 2 | 2010 | 99 | 0.090 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2011 | 13 | 0.090 |
Why?
|
| RNA | 1 | 2015 | 426 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 660 | 0.090 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2008 | 246 | 0.080 |
Why?
|
| Immunoglobulin Variable Region | 2 | 2000 | 34 | 0.080 |
Why?
|
| Cysteine | 1 | 2010 | 107 | 0.070 |
Why?
|
| Peptide Fragments | 1 | 2011 | 416 | 0.070 |
Why?
|
| CD4 Antigens | 2 | 2006 | 149 | 0.070 |
Why?
|
| Interferon-gamma | 6 | 2010 | 574 | 0.070 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2009 | 112 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1142 | 0.070 |
Why?
|
| Multiple Sclerosis | 1 | 2011 | 226 | 0.070 |
Why?
|
| Immunoassay | 1 | 2008 | 71 | 0.070 |
Why?
|
| Inflammation Mediators | 1 | 2009 | 181 | 0.070 |
Why?
|
| Genes, myc | 2 | 2001 | 18 | 0.070 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2008 | 40 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2010 | 211 | 0.070 |
Why?
|
| Antigen-Presenting Cells | 2 | 2005 | 179 | 0.070 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2008 | 37 | 0.070 |
Why?
|
| Cysteine Endopeptidases | 1 | 2008 | 96 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2026 | 1285 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 130 | 0.070 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2008 | 178 | 0.070 |
Why?
|
| Graft Survival | 1 | 2008 | 297 | 0.070 |
Why?
|
| Monocytes | 1 | 2009 | 362 | 0.070 |
Why?
|
| Lysosomes | 1 | 2008 | 171 | 0.060 |
Why?
|
| Graft Rejection | 1 | 2008 | 302 | 0.060 |
Why?
|
| Cell Communication | 2 | 2021 | 134 | 0.060 |
Why?
|
| Glioblastoma | 1 | 2008 | 159 | 0.060 |
Why?
|
| Tissue Donors | 2 | 2021 | 147 | 0.060 |
Why?
|
| Biomarkers | 2 | 2022 | 1466 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2009 | 1383 | 0.060 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2025 | 27 | 0.060 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 2005 | 27 | 0.060 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2025 | 27 | 0.060 |
Why?
|
| Apolipoproteins E | 1 | 2005 | 114 | 0.060 |
Why?
|
| Tuberculosis | 1 | 2008 | 303 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2017 | 2052 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2005 | 336 | 0.050 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2008 | 417 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2024 | 116 | 0.050 |
Why?
|
| Alleles | 1 | 2005 | 454 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2022 | 666 | 0.050 |
Why?
|
| Lymphoma, B-Cell | 2 | 1994 | 61 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2009 | 921 | 0.050 |
Why?
|
| Salmonella Infections | 1 | 2003 | 42 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2024 | 135 | 0.050 |
Why?
|
| Cyclin I | 1 | 2023 | 1 | 0.050 |
Why?
|
| Secretory Vesicles | 1 | 2023 | 24 | 0.050 |
Why?
|
| Middle Aged | 6 | 2015 | 18122 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2025 | 440 | 0.050 |
Why?
|
| Glutamate Decarboxylase | 1 | 2002 | 21 | 0.050 |
Why?
|
| CD3 Complex | 2 | 2018 | 64 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2002 | 129 | 0.040 |
Why?
|
| Immunoconjugates | 1 | 2002 | 95 | 0.040 |
Why?
|
| Bursa of Fabricius | 1 | 2001 | 1 | 0.040 |
Why?
|
| Cell Transformation, Viral | 1 | 2001 | 15 | 0.040 |
Why?
|
| Cellular Microenvironment | 1 | 2021 | 22 | 0.040 |
Why?
|
| Antibodies, Heterophile | 1 | 2001 | 1 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2024 | 325 | 0.040 |
Why?
|
| Lymphoma | 1 | 2001 | 101 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2025 | 793 | 0.040 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2011 | 92 | 0.040 |
Why?
|
| Twins | 1 | 2000 | 52 | 0.040 |
Why?
|
| HLA Antigens | 1 | 2020 | 62 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2002 | 3148 | 0.040 |
Why?
|
| HIV-1 | 1 | 2005 | 704 | 0.040 |
Why?
|
| DNA | 2 | 1999 | 846 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 1999 | 173 | 0.040 |
Why?
|
| Base Sequence | 2 | 1999 | 1327 | 0.040 |
Why?
|
| Coculture Techniques | 2 | 2009 | 103 | 0.040 |
Why?
|
| Transglutaminases | 1 | 2018 | 14 | 0.040 |
Why?
|
| HIV Infections | 1 | 2005 | 951 | 0.030 |
Why?
|
| Glucagon | 1 | 2018 | 33 | 0.030 |
Why?
|
| Insecta | 1 | 2018 | 36 | 0.030 |
Why?
|
| Dexamethasone | 1 | 1999 | 211 | 0.030 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2018 | 88 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 2018 | 94 | 0.030 |
Why?
|
| Interleukin-6 | 2 | 2009 | 323 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2018 | 389 | 0.030 |
Why?
|
| Goats | 1 | 2017 | 11 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2017 | 38 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2018 | 313 | 0.030 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2016 | 15 | 0.030 |
Why?
|
| Thiazoles | 1 | 2016 | 45 | 0.030 |
Why?
|
| Rabbits | 1 | 2017 | 337 | 0.030 |
Why?
|
| Indoles | 1 | 2016 | 111 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2017 | 403 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2015 | 36 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 181 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 2270 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2000 | 1635 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2009 | 1029 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1994 | 112 | 0.020 |
Why?
|
| Phenotype | 1 | 2017 | 1236 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 694 | 0.020 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2011 | 9 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 794 | 0.020 |
Why?
|
| Inflammation | 1 | 2018 | 1185 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2011 | 125 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2009 | 876 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 2608 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 237 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2011 | 181 | 0.020 |
Why?
|
| Quantum Theory | 1 | 2010 | 8 | 0.020 |
Why?
|
| Histocompatibility Testing | 1 | 2010 | 32 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2016 | 543 | 0.020 |
Why?
|
| Hyperinsulinism | 1 | 2010 | 26 | 0.020 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2010 | 26 | 0.020 |
Why?
|
| Hepatitis A Virus Cellular Receptor 2 | 1 | 2009 | 15 | 0.020 |
Why?
|
| Galectins | 1 | 2009 | 9 | 0.020 |
Why?
|
| Age of Onset | 1 | 2010 | 173 | 0.020 |
Why?
|
| Mutation | 1 | 2018 | 2667 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2010 | 323 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2010 | 277 | 0.020 |
Why?
|
| Biological Transport, Active | 1 | 2008 | 38 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2009 | 109 | 0.020 |
Why?
|
| Autopsy | 1 | 2008 | 56 | 0.020 |
Why?
|
| CD56 Antigen | 1 | 2008 | 16 | 0.020 |
Why?
|
| Portal Vein | 1 | 2008 | 39 | 0.020 |
Why?
|
| Phagosomes | 1 | 2008 | 54 | 0.020 |
Why?
|
| Atrophy | 1 | 2008 | 87 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 2008 | 21 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2008 | 123 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 295 | 0.020 |
Why?
|
| Aged | 2 | 2017 | 14848 | 0.020 |
Why?
|
| HLA-D Antigens | 1 | 2008 | 19 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2009 | 273 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2008 | 206 | 0.020 |
Why?
|
| Meningioma | 1 | 2008 | 62 | 0.020 |
Why?
|
| Pregnancy | 1 | 2015 | 2361 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2009 | 281 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 2008 | 106 | 0.020 |
Why?
|
| Cell Division | 2 | 2002 | 448 | 0.020 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2006 | 8 | 0.020 |
Why?
|
| CD8 Antigens | 1 | 2006 | 53 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2008 | 268 | 0.020 |
Why?
|
| Cell Count | 1 | 2006 | 131 | 0.020 |
Why?
|
| Mustard Compounds | 1 | 1986 | 1 | 0.020 |
Why?
|
| Mustard Gas | 1 | 1986 | 2 | 0.020 |
Why?
|
| Protein Binding | 1 | 2011 | 1640 | 0.020 |
Why?
|
| Kinetics | 1 | 2008 | 758 | 0.020 |
Why?
|
| Deoxyguanosine | 1 | 1986 | 18 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2006 | 90 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2006 | 200 | 0.010 |
Why?
|
| Methyltransferases | 1 | 1986 | 67 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 225 | 0.010 |
Why?
|
| Receptors, LDL | 1 | 2005 | 35 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2008 | 507 | 0.010 |
Why?
|
| Ionophores | 1 | 2005 | 11 | 0.010 |
Why?
|
| Ionomycin | 1 | 2005 | 16 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 543 | 0.010 |
Why?
|
| Arthritis, Experimental | 1 | 2005 | 30 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2005 | 62 | 0.010 |
Why?
|
| Carcinogens | 1 | 2005 | 33 | 0.010 |
Why?
|
| Membrane Fusion | 1 | 2005 | 68 | 0.010 |
Why?
|
| DNA Repair | 1 | 1986 | 251 | 0.010 |
Why?
|
| Endosomes | 1 | 2005 | 181 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2005 | 224 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2009 | 829 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2003 | 127 | 0.010 |
Why?
|
| Salmonella typhimurium | 1 | 2003 | 84 | 0.010 |
Why?
|
| B7-2 Antigen | 1 | 2002 | 32 | 0.010 |
Why?
|
| Interleukin-13 | 1 | 2002 | 37 | 0.010 |
Why?
|
| Abatacept | 1 | 2002 | 67 | 0.010 |
Why?
|
| CTLA-4 Antigen | 1 | 2002 | 73 | 0.010 |
Why?
|
| CD28 Antigens | 1 | 2002 | 61 | 0.010 |
Why?
|
| B7-1 Antigen | 1 | 2002 | 74 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 2002 | 142 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 701 | 0.010 |
Why?
|
| Rats | 1 | 2005 | 1997 | 0.010 |
Why?
|
| Avian Leukosis Virus | 1 | 2001 | 3 | 0.010 |
Why?
|
| Apoptosis | 2 | 1999 | 1091 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2001 | 46 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 706 | 0.010 |
Why?
|
| Cell Line | 1 | 2005 | 2036 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2002 | 346 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2003 | 618 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2001 | 450 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1999 | 50 | 0.010 |
Why?
|
| Antibodies, Blocking | 1 | 1999 | 39 | 0.010 |
Why?
|
| Autocrine Communication | 1 | 1999 | 30 | 0.010 |
Why?
|
| fas Receptor | 1 | 1999 | 56 | 0.010 |
Why?
|
| Cell Movement | 1 | 2001 | 476 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 1999 | 167 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 664 | 0.010 |
Why?
|
| Triplets | 1 | 1998 | 2 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 1999 | 234 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 1998 | 71 | 0.010 |
Why?
|
| Twins, Monozygotic | 1 | 1998 | 72 | 0.010 |
Why?
|
| Diseases in Twins | 1 | 1998 | 56 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 1999 | 379 | 0.010 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 1994 | 13 | 0.010 |
Why?
|
| Retinoblastoma Protein | 1 | 1994 | 45 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2001 | 2679 | 0.010 |
Why?
|
| Disease Progression | 1 | 1998 | 1211 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1994 | 426 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 1994 | 181 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1994 | 149 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1994 | 396 | 0.010 |
Why?
|
| Phosphorylation | 1 | 1994 | 961 | 0.010 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 1986 | 4 | 0.000 |
Why?
|
| Alkylation | 1 | 1986 | 9 | 0.000 |
Why?
|
| Guanine | 1 | 1986 | 25 | 0.000 |
Why?
|
| Adenine | 1 | 1986 | 49 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1986 | 221 | 0.000 |
Why?
|
| Cattle | 1 | 1986 | 318 | 0.000 |
Why?
|